Search research articles
Contact Us
Filters
Showing results (371-380 of 383) with videos related to
Page
of 39
Sort By:
Endocrine-Related Cancer
|
August 23, 2005
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment
J M W Gee, A Howell, W J Gullick, et al.
Journal of Hepatology
|
October 3, 2021
ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD
Kathleen E Corey, Rebecca Pitts, Michelle Lai, et al.
Human Molecular Genetics
|
July 6, 2016
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer
Michael J G Milevskiy, Fares Al-Ejeh, Jodi M Saunus, et al.
Hepatology Communications
|
September 24, 2021
Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity
Sonu Subudhi, Hannah K Drescher, Laura E Dichtel, et al.
Nature Communications
|
January 18, 2020
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Fatima Valdes-Mora, Phuc-Loi Luu, et al.
The FEBS Journal
|
July 24, 2013
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
Brigid C Browne, Falko Hochgräfe, Jianmin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2019
Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER<sup>+</sup> Invasive Breast Cancer (STAKT)
John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, et al.
Nature Structural & Molecular Biology
|
January 5, 2024
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2022
Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, et al.
NPJ Breast Cancer
|
May 2, 2022
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
Jodi M Saunus, Xavier M De Luca, Korinne Northwood, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 383) with videos related to
Sort By:
Page
of 39
Endocrine-Related Cancer
|
August 23, 2005
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment
J M W Gee, A Howell, W J Gullick, et al.
Journal of Hepatology
|
October 3, 2021
ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD
Kathleen E Corey, Rebecca Pitts, Michelle Lai, et al.
Human Molecular Genetics
|
July 6, 2016
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer
Michael J G Milevskiy, Fares Al-Ejeh, Jodi M Saunus, et al.
Hepatology Communications
|
September 24, 2021
Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity
Sonu Subudhi, Hannah K Drescher, Laura E Dichtel, et al.
Nature Communications
|
January 18, 2020
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Fatima Valdes-Mora, Phuc-Loi Luu, et al.
The FEBS Journal
|
July 24, 2013
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
Brigid C Browne, Falko Hochgräfe, Jianmin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2019
Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER<sup>+</sup> Invasive Breast Cancer (STAKT)
John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, et al.
Nature Structural & Molecular Biology
|
January 5, 2024
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2022
Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, et al.
NPJ Breast Cancer
|
May 2, 2022
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
Jodi M Saunus, Xavier M De Luca, Korinne Northwood, et al.
Page
of 39